• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Nrf3通过激活PI3K/AKT/mTOR和上皮-间质转化来促进三阴性乳腺癌的增殖和迁移。

Nrf3 promotes the proliferation and migration of triple‑negative breast cancer by activating PI3K/AKT/mTOR and epithelial‑mesenchymal transition.

作者信息

Chen Wan-Meng, Hu Qing-Yong, Hou Wei, Chen Meng-Wei, Chen Ya-Hui, Tang Jian-Cai

机构信息

Department of Biochemistry, Institute of Basic Medicine and Forensics Medicine, North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China.

出版信息

Oncol Lett. 2023 Aug 28;26(4):443. doi: 10.3892/ol.2023.14030. eCollection 2023 Oct.

DOI:10.3892/ol.2023.14030
PMID:37720674
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10502936/
Abstract

Nuclear factor erythroid 2-related factor 3 (Nrf3) is increasingly implicated in multiple types of cancer; however, its function in triple-negative breast cancer (TNBC) remains unclear. This study aimed to examine the role of Nrf3 in TNBC. Compared with adjacent normal tissues, TNBC tissues expressed higher levels of Nrf3, and its expression was negatively correlated with survival time. Additionally, Nrf3 knockdown reduced the proliferation and migration of TNBC cells, whereas overexpression of Nrf3 had the opposite effects and . Moreover, functional enrichment of TNBC cells overexpressing Nrf3 allowed for the identification of numerous genes and pathways that were altered following Nrf3 overexpression. Further study showed that overexpression of Nrf3 activated the PI3K/AKT/mTOR signaling pathway and regulated the expression of proteins associated with epithelial-mesenchymal transition. Nrf3 was found to directly bind to p110α promoter regions, as evidenced by luciferase reporter and chromatin immunoprecipitation assays. Furthermore, PI3K inhibitors partially decreased the proliferation and migration of the Nrf3 overexpressing TNBC cells. In conclusion, Nrf3 enhances cellular proliferation and migration by activating PI3K/AKT/mTOR signaling pathways, highlighting a novel therapeutic target for TNBC.

摘要

核因子红细胞2相关因子3(Nrf3)越来越多地与多种癌症相关;然而,其在三阴性乳腺癌(TNBC)中的功能仍不清楚。本研究旨在探讨Nrf3在TNBC中的作用。与相邻正常组织相比,TNBC组织中Nrf3表达水平更高,且其表达与生存时间呈负相关。此外,敲低Nrf3可降低TNBC细胞的增殖和迁移,而Nrf3过表达则产生相反的效果。此外,对过表达Nrf3的TNBC细胞进行功能富集分析,可鉴定出Nrf3过表达后发生改变的众多基因和信号通路。进一步研究表明,Nrf3过表达激活了PI3K/AKT/mTOR信号通路,并调节了与上皮-间质转化相关的蛋白质表达。荧光素酶报告基因和染色质免疫沉淀实验证明,Nrf3可直接结合到p110α启动子区域。此外,PI3K抑制剂可部分降低过表达Nrf3的TNBC细胞的增殖和迁移。总之,Nrf3通过激活PI3K/AKT/mTOR信号通路增强细胞增殖和迁移,为TNBC提供了一个新的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/c6942a8af299/ol-26-04-14030-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/509a6007d7f1/ol-26-04-14030-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/dfb6bf653a55/ol-26-04-14030-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/54bbab263f37/ol-26-04-14030-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/e149342cd3ff/ol-26-04-14030-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/0a99fb4cde44/ol-26-04-14030-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/78b81b739494/ol-26-04-14030-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/c6942a8af299/ol-26-04-14030-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/509a6007d7f1/ol-26-04-14030-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/dfb6bf653a55/ol-26-04-14030-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/54bbab263f37/ol-26-04-14030-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/e149342cd3ff/ol-26-04-14030-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/0a99fb4cde44/ol-26-04-14030-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/78b81b739494/ol-26-04-14030-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c10/10502936/c6942a8af299/ol-26-04-14030-g06.jpg

相似文献

1
Nrf3 promotes the proliferation and migration of triple‑negative breast cancer by activating PI3K/AKT/mTOR and epithelial‑mesenchymal transition.Nrf3通过激活PI3K/AKT/mTOR和上皮-间质转化来促进三阴性乳腺癌的增殖和迁移。
Oncol Lett. 2023 Aug 28;26(4):443. doi: 10.3892/ol.2023.14030. eCollection 2023 Oct.
2
NRF3 suppresses the metastasis of triple-negative breast cancer cells by inhibiting ERK activation in a ROS-dependent manner.NRF3通过以ROS依赖的方式抑制ERK激活来抑制三阴性乳腺癌细胞的转移。
Histol Histopathol. 2025 Jan;40(1):123-131. doi: 10.14670/HH-18-786. Epub 2024 Jun 26.
3
Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.微线体家族 CW 型锌指蛋白 2 通过结合 N‑myc 下游调节基因 1 启动子调控 PTEN/PI3K/AKT 信号通路,促进胶质瘤的增殖、侵袭、迁移和上皮间质转化。
Int J Mol Med. 2022 Feb;49(2). doi: 10.3892/ijmm.2021.5071. Epub 2021 Dec 16.
4
Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.毛蕊异黄酮通过下调新型雌激素受体-α剪接变体 ER-α30 介导的 PI3K/AKT 信号通路抑制三阴性乳腺癌的进展。
Phytomedicine. 2023 Sep;118:154924. doi: 10.1016/j.phymed.2023.154924. Epub 2023 Jun 14.
5
Actin-Like Protein 8 Promotes the Progression of Triple-Negative Breast Cancer via Activating PI3K/AKT/mTOR Pathway.肌动蛋白样蛋白8通过激活PI3K/AKT/mTOR信号通路促进三阴性乳腺癌进展。
Onco Targets Ther. 2021 Apr 12;14:2463-2473. doi: 10.2147/OTT.S291403. eCollection 2021.
6
NRF3 suppresses breast cancer cell metastasis and cell proliferation and is a favorable predictor of survival in breast cancer.NRF3抑制乳腺癌细胞转移和细胞增殖,是乳腺癌生存的一个良好预测指标。
Onco Targets Ther. 2019 Apr 18;12:3019-3030. doi: 10.2147/OTT.S197409. eCollection 2019.
7
PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K/AKT/mTOR signaling pathway.PIK3CA突变通过抑制细胞凋亡和激活PI3K/AKT/mTOR信号通路,赋予三阴性乳腺癌对化疗的抗性。
Ann Transl Med. 2021 Mar;9(5):410. doi: 10.21037/atm-21-698.
8
DEK promoted EMT and angiogenesis through regulating PI3K/AKT/mTOR pathway in triple-negative breast cancer.DEK通过调节三阴性乳腺癌中的PI3K/AKT/mTOR通路促进上皮-间质转化和血管生成。
Oncotarget. 2017 Oct 17;8(58):98708-98722. doi: 10.18632/oncotarget.21864. eCollection 2017 Nov 17.
9
Effecacy of Biejia (Carapax Trionycis) and Ezhu (Rhizoma Curcumae Phaeocaulis) couplet medicine on epithelial-mesenchymal transition, invasion and migration of MDA-MB-231 triple negative breast cancer cells via PI3K/Akt/mTOR signaling pathway.鳖甲莪术药对通过 PI3K/Akt/mTOR 信号通路对 MDA-MB-231 三阴性乳腺癌细胞上皮-间充质转化、侵袭和迁移的影响。
J Tradit Chin Med. 2021 Dec;41(6):853-861. doi: 10.19852/j.cnki.jtcm.2021.06.004.
10
KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer PI3K/AKT/mTOR Signaling Pathway.驱动蛋白家族成员C3(KIFC3)通过PI3K/AKT/mTOR信号通路促进结直肠癌的增殖、迁移和侵袭。
Front Genet. 2022 Jun 22;13:848926. doi: 10.3389/fgene.2022.848926. eCollection 2022.

引用本文的文献

1
Treatment strategies targeting the phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin pathway against triple-negative breast cancer.针对磷酸肌醇3激酶/蛋白激酶B/雷帕霉素作用机制靶点通路治疗三阴性乳腺癌的策略
World J Clin Oncol. 2025 May 24;16(5):104623. doi: 10.5306/wjco.v16.i5.104623.

本文引用的文献

1
Simultaneous glutamine metabolism and PD-L1 inhibition to enhance suppression of triple-negative breast cancer.同时抑制谷氨酰胺代谢和 PD-L1 以增强对三阴性乳腺癌的抑制作用。
J Nanobiotechnology. 2022 May 6;20(1):216. doi: 10.1186/s12951-022-01424-7.
2
NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma.NRF3 在黑色素瘤发生过程中减少,并且是黑色素瘤的独立预后标志物。
Oxid Med Cell Longev. 2022 Mar 26;2022:2240223. doi: 10.1155/2022/2240223. eCollection 2022.
3
NFE2L3 promotes tumor progression and predicts a poor prognosis of bladder cancer.
NFE2L3 促进膀胱癌的肿瘤进展并预测不良预后。
Carcinogenesis. 2022 Jun 4;43(5):457-468. doi: 10.1093/carcin/bgac006.
4
The Role of ATRA, Natural Ligand of Retinoic Acid Receptors, on EMT-Related Proteins in Breast Cancer: Minireview.维甲酸受体的天然配体 ATRA 在乳腺癌 EMT 相关蛋白中的作用:综述。
Int J Mol Sci. 2021 Dec 12;22(24):13345. doi: 10.3390/ijms222413345.
5
Nrf3 Promotes 5-FU Resistance in Colorectal Cancer Cells via the NF-B/BCL-2 Signaling Pathway In Vitro and In Vivo.Nrf3通过NF-κB/BCL-2信号通路在体外和体内促进结肠癌细胞对5-氟尿嘧啶的耐药性。
J Oncol. 2021 Nov 9;2021:9355555. doi: 10.1155/2021/9355555. eCollection 2021.
6
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
7
Roles of CNC Transcription Factors NRF1 and NRF2 in Cancer.CNC转录因子NRF1和NRF2在癌症中的作用。
Cancers (Basel). 2021 Feb 1;13(3):541. doi: 10.3390/cancers13030541.
8
Distinct epithelial-to-mesenchymal transitions induced by and .和 诱导的不同上皮-间充质转化。
J Cell Sci. 2021 Feb 17;134(4):jcs248294. doi: 10.1242/jcs.248294.
9
PI3K/AKT/mTOR Signaling Pathway in Breast Cancer: From Molecular Landscape to Clinical Aspects.PI3K/AKT/mTOR 信号通路在乳腺癌中的作用:从分子特征到临床应用。
Int J Mol Sci. 2020 Dec 26;22(1):173. doi: 10.3390/ijms22010173.
10
NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt/β‑catenin pathway.NFE2L3通过Wnt/β-连环蛋白信号通路促进人肝癌(HepG2)细胞的恶性行为和上皮-间质转化。
J Cancer. 2020 Oct 8;11(23):6939-6949. doi: 10.7150/jca.48100. eCollection 2020.